DE69501791D1 - Indol-derivate als 5-ht1-like agonisten - Google Patents
Indol-derivate als 5-ht1-like agonistenInfo
- Publication number
- DE69501791D1 DE69501791D1 DE69501791T DE69501791T DE69501791D1 DE 69501791 D1 DE69501791 D1 DE 69501791D1 DE 69501791 T DE69501791 T DE 69501791T DE 69501791 T DE69501791 T DE 69501791T DE 69501791 D1 DE69501791 D1 DE 69501791D1
- Authority
- DE
- Germany
- Prior art keywords
- pct
- date apr
- sec
- alkyl
- pharmaceutically acceptable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Anesthesiology (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Child & Adolescent Psychology (AREA)
- Toxicology (AREA)
- Obesity (AREA)
- Hospice & Palliative Care (AREA)
- Otolaryngology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Indole Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9420503A GB9420503D0 (en) | 1994-10-11 | 1994-10-11 | Therapeutic agents |
PCT/EP1995/003884 WO1996011195A1 (en) | 1994-10-11 | 1995-09-29 | Indole derivatives as 5ht1-like agonists |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69501791D1 true DE69501791D1 (de) | 1998-04-16 |
DE69501791T2 DE69501791T2 (de) | 1998-07-02 |
Family
ID=10762688
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69501791T Expired - Fee Related DE69501791T2 (de) | 1994-10-11 | 1995-09-29 | Indol-derivate als 5-ht1-like agonisten |
Country Status (11)
Country | Link |
---|---|
US (1) | US5770611A (de) |
EP (1) | EP0785933B1 (de) |
JP (1) | JP2902484B2 (de) |
AT (1) | ATE163934T1 (de) |
DE (1) | DE69501791T2 (de) |
DK (1) | DK0785933T3 (de) |
ES (1) | ES2113213T3 (de) |
FI (1) | FI113863B (de) |
GB (1) | GB9420503D0 (de) |
GR (1) | GR3026532T3 (de) |
WO (1) | WO1996011195A1 (de) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9420529D0 (en) | 1994-10-12 | 1994-11-30 | Pfizer Ltd | Indoles |
EP1043324B1 (de) | 1997-11-12 | 2004-06-16 | Mitsubishi Chemical Corporation | Purinderivate und medikamente, welche dieselben als aktiven bestandteil enthalten |
AU1708099A (en) | 1998-06-03 | 1999-12-20 | Amgen, Inc. | N-linked sulfonamides of n-heterocyclic carboxylic acids or carboxylic acid isosteres |
KR100747106B1 (ko) | 1999-05-11 | 2007-08-08 | 미쯔비시 가가꾸 가부시끼가이샤 | 퓨린 유도체 이수화물, 이를 유효성분으로 함유하는 의약및 이의 제조 중간체 |
WO2011158149A1 (en) | 2010-06-18 | 2011-12-22 | Pfizer Inc. | 2-(3,5-disubstitutedphenyl)pyrimidin-4(3h)-one derivatives |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5559246A (en) * | 1990-10-15 | 1996-09-24 | Pfizer Inc. | Indole derivatives |
US5578612A (en) * | 1990-10-15 | 1996-11-26 | Pfizer Inc. | Indole derivatives |
US5545644A (en) * | 1990-10-15 | 1996-08-13 | Pfizer Inc. | Indole derivatives |
US5559129A (en) * | 1990-10-15 | 1996-09-24 | Pfizer Inc | Indole derivatives |
US5607951A (en) * | 1990-10-15 | 1997-03-04 | Pfizer Inc | Indole derivatives |
UA41297C2 (uk) * | 1991-11-25 | 2001-09-17 | Пфайзер, Інк. | Похідні індолу, фармацевтична композиція і спосіб лікування |
US5409941A (en) * | 1992-02-03 | 1995-04-25 | Pfizer Inc. | 5-heteroyl indole derivatives |
TW288010B (de) * | 1992-03-05 | 1996-10-11 | Pfizer | |
DE69307875T2 (de) * | 1992-04-10 | 1997-05-22 | Pfizer | Acylaminoindolderivate als 5-ht1 agonisten |
GB9207930D0 (en) * | 1992-04-10 | 1992-05-27 | Pfizer Ltd | Indoles |
GB9208161D0 (en) * | 1992-04-14 | 1992-05-27 | Pfizer Ltd | Indoles |
CA2157397C (en) * | 1993-04-22 | 1999-07-06 | Martin James Wythes | Indole derivatives as 5-ht1-like agonists for use in migraine |
GB9424471D0 (en) * | 1994-12-03 | 1995-01-18 | Pfizer Ltd | Treatment of emesis |
-
1994
- 1994-10-11 GB GB9420503A patent/GB9420503D0/en active Pending
-
1995
- 1995-09-29 ES ES95934124T patent/ES2113213T3/es not_active Expired - Lifetime
- 1995-09-29 WO PCT/EP1995/003884 patent/WO1996011195A1/en active IP Right Grant
- 1995-09-29 JP JP8512312A patent/JP2902484B2/ja not_active Expired - Fee Related
- 1995-09-29 DE DE69501791T patent/DE69501791T2/de not_active Expired - Fee Related
- 1995-09-29 US US08/809,600 patent/US5770611A/en not_active Expired - Fee Related
- 1995-09-29 AT AT95934124T patent/ATE163934T1/de not_active IP Right Cessation
- 1995-09-29 DK DK95934124.9T patent/DK0785933T3/da active
- 1995-09-29 EP EP95934124A patent/EP0785933B1/de not_active Expired - Lifetime
-
1997
- 1997-04-10 FI FI971492A patent/FI113863B/fi active
-
1998
- 1998-04-03 GR GR980400716T patent/GR3026532T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
FI113863B (fi) | 2004-06-30 |
US5770611A (en) | 1998-06-23 |
GR3026532T3 (en) | 1998-07-31 |
ES2113213T3 (es) | 1998-04-16 |
MX9702643A (es) | 1997-07-31 |
JPH09512034A (ja) | 1997-12-02 |
FI971492A (fi) | 1997-04-10 |
FI971492A0 (fi) | 1997-04-10 |
ATE163934T1 (de) | 1998-03-15 |
GB9420503D0 (en) | 1994-11-23 |
DK0785933T3 (da) | 1998-05-11 |
EP0785933A1 (de) | 1997-07-30 |
EP0785933B1 (de) | 1998-03-11 |
WO1996011195A1 (en) | 1996-04-18 |
JP2902484B2 (ja) | 1999-06-07 |
DE69501791T2 (de) | 1998-07-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2157397A1 (en) | Indole derivatives as 5-ht1-like agonists for use in migraine | |
EP0354777A3 (de) | 3-(4-Piperidin)-5-(2-sulphonylaminoethyl)-indol-Derivate | |
PT729455E (pt) | Arilpiperazinas derivadas de indol como ligados para os receptores 5ht1-like, 5ht1b e 5ht1d | |
PT87183A (pt) | Procede de preparation de derives d:aryl-heteroaryl carbinol avec activite analgesique | |
ATE17249T1 (de) | 9-(2-(3-indolyl)aethyl)-1-oxa-4,9diazaspiro(5.5)undecan-3-one. | |
NO943261D0 (no) | Indolderivater som 5-HT, agonister | |
DK0677046T3 (da) | Piperazinderivater som 5-HT-antagonister. | |
NO996453L (no) | Nye tricykliske forbindelser med mettede ringer, samt medisinske blandinger inneholdende forbindelsene | |
NO893480D0 (no) | Fremgangsmaate for fremstilling av disubstituerte benzylaminer. | |
ATE133169T1 (de) | Indol derivate als ''5-ht1-like'' agonisten | |
ATE117677T1 (de) | Indolderivate. | |
DE69501791D1 (de) | Indol-derivate als 5-ht1-like agonisten | |
FI943931A0 (fi) | Indolijohdannaisia steroidi-5alfa-reduktaasin inhibiittoreina | |
NO179865C (no) | Nytt -fenylisoserinderivat og dets fremstilling | |
DK0871626T3 (da) | Triazoloner som apolipoprotein-B syntheseinhibitorer | |
ES2128572T3 (es) | Utilizacion de los derivados de cefem como agentes antimetastaticos. | |
CA2202348A1 (en) | Indole derivatives as 5ht1-like agonists | |
NO985685D0 (no) | Dibenzo-oksazepin- og -dioksazepin-derivater og deres anvendelse som anti-tumormidler | |
NO961719L (no) | 3-aryl-4-alkyl og 4,5-dialkyl-4H-1,2,4-triazoler som er anvendbare som hukommelsesforsterkere | |
ES2070087A1 (es) | Derivados de indol | |
CA2350089A1 (en) | Indole derivatives |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8327 | Change in the person/name/address of the patent owner |
Owner name: PFIZER IRELAND PHARMACEUTICALS, DUBLIN, IE |
|
8339 | Ceased/non-payment of the annual fee |